[
    [
        {
            "time": "2021-08-16",
            "original_text": "凯莱英半年报见光股价跌停 ROE主营业务毛利率均降 盈利能力下降",
            "features": {
                "keywords": [
                    "凯莱英",
                    "半年报",
                    "ROE",
                    "毛利率",
                    "盈利能力下降"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "CDMO"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "凯莱英半年报见光股价跌停 ROE主营业务毛利率均降 盈利能力下降",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-08-16",
            "original_text": "高瓴巨额减持220万股，20倍医药大白马跌停，股民一天亏38万",
            "features": {
                "keywords": [
                    "高瓴资本",
                    "减持",
                    "凯莱英",
                    "医药白马股",
                    "跌停"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "高瓴巨额减持220万股，20倍医药大白马跌停，股民一天亏38万",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 9,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-08-16",
            "original_text": "平安证券维持凯莱英强烈推荐评级，汇兑影响观增速，订单+产能双双加速保障后续发展",
            "features": {
                "keywords": [
                    "凯莱英",
                    "平安证券",
                    "强烈推荐",
                    "汇兑影响",
                    "订单",
                    "产能"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "CDMO"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "平安证券维持凯莱英强烈推荐评级，汇兑影响观增速，订单+产能双双加速保障后续发展",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-08-16",
            "original_text": "东吴证券：维持凯莱英“买入”评级 在手订单充沛 新兴服务拓展效果显著",
            "features": {
                "keywords": [
                    "凯莱英",
                    "东吴证券",
                    "买入评级",
                    "订单",
                    "新兴服务"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "CDMO"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "东吴证券：维持凯莱英“买入”评级 在手订单充沛 新兴服务拓展效果显著",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-08-16",
            "original_text": "罕见跌停！高瓴二季度巨额减持凯莱英，葛兰李晓西加仓！邓晓峰冯明远二季度看这些标的！ 减持股份",
            "features": {
                "keywords": [
                    "凯莱英",
                    "高瓴资本",
                    "减持",
                    "葛兰",
                    "李晓西",
                    "加仓"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "罕见跌停！高瓴二季度巨额减持凯莱英，葛兰李晓西加仓！邓晓峰冯明远二季度看这些标的！ 减持股份",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]